VEGF Gene Transfected Human BMSCs Acting as Seeding Cell for Tissue Engineering Bond in Orbital Wall Bone Defects

Caiwen XIAO,Xianqun FAN,Huifang ZHOU,Xiaoping BI,Qin SHEN,Yefei WANG

DOI: https://doi.org/10.3969/j.issn.1673-0364.2009.04.002

2009-01-01

Abstract:Objective To investigate the effect VEGF-gene transfected BMSCs to construct tissue engineered bone in the treatment of orbital wall bone defects.Methods In vitro isolated and expanded BMSCs of passage 2 were transfected with adenoviruses containing human VEGF gene,and the target gene expression was evaluated by Real-time PCR and Western Blot.BMSCs were harvested and seeded into the coral scaffolds to construct tissue engineered bone.VEGF protein secretion from the cells was detected using Elisa method.Bilateral orbital wall circular defects(12 mm in diameter) were created in 24 adult beagles dogs.The dogs were divided into 5 groups,the group trasfected by VEGF(Group A),the non-transfected group(Group B),the group implanted coral alone(Group C),and blank group(Group D).Animals were sacrificed at 4,12 and 24 weeks post-implantation,and the repairing effect was evaluated by gross observation,Micro-CT,immunohistochemistry,and histomorphometric analysis.Results VEGF gene expression was regulated after gene transfection,and protein secretion was detected 22 days after cell seeding.No repair was found in Groups C and D.The number of new blood vessel and volume of new bone were significantly higher in Group A than in Group B at 4 weeks after implantation(P<0.05),but no statistically significant at 12 and 24 weeks(P>0.05).Conclusion Tissue-engineered bone composed of VEGF-expressing BMSCs could enhance the formation of blood vessel and bone at early periods in vivo.